Novavax Inc - Company & Market Research Reports

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast, 2016 to 2022 - Product Thumbnail Image

Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast, 2016 to 2022

  • Drug Pipelines
  • 205 Pages
From
Global Virus Like Particles Market & Clinical Trial Insight 2023 - Product Thumbnail Image

Global Virus Like Particles Market & Clinical Trial Insight 2023

  • Clinical Trials
  • 180 Pages
From
Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Swine and Avian Influenza Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Swine and Avian Influenza Drug Development Pipeline Review, 2017

  • Report
  • 119 Pages
From
Opportunity Analysis of H1N1 (swine flu) Vaccination Market - Product Thumbnail Image

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

  • Report
  • 126 Pages
From
Global Human Respiratory Syncytial Virus Drugs Market 2016-2020 - Product Thumbnail Image

Global Human Respiratory Syncytial Virus Drugs Market 2016-2020

  • Report
  • 74 Pages
From
Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 - Product Thumbnail Image

Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Report
  • 190 Pages
From
Prophylactic Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Prophylactic Human Vaccines - Global Strategic Business Report

  • Report
  • 358 Pages
From
Vaccine Contract Manufacturing Market, 2016 - 2026 - Product Thumbnail Image

Vaccine Contract Manufacturing Market, 2016 - 2026

  • Report
  • 265 Pages
From
Global Travel Vaccines Market 2016-2020 - Product Thumbnail Image

Global Travel Vaccines Market 2016-2020

  • Report
  • 60 Pages
From
Vaccine Adjuvants Market Size And Forecast By Type, By Application, And Trend Analysis, 2014 - 2025 - Product Thumbnail Image

Vaccine Adjuvants Market Size And Forecast By Type, By Application, And Trend Analysis, 2014 - 2025

  • Report
  • 90 Pages
From
Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts - Product Thumbnail Image

Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts

  • Report
  • 175 Pages
From
Global Influenza Vaccine Market 2018-2022 - Product Thumbnail Image

Global Influenza Vaccine Market 2018-2022

  • Report
  • 113 Pages
From
Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021 - Product Thumbnail Image

Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021

  • Report
  • 159 Pages
From
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018

  • Drug Pipelines
  • 241 Pages
From
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016 - Product Thumbnail Image

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 132 Pages
From
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2018 - Product Thumbnail Image

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 144 Pages
From
Loading Indicator
adroll